Evidence map›Paper›PMID 34124768›Full record

ArticleHistology and histopathology2021

Expressions of CXCL12, CXCL10 and CCL18 in Warthin tumors characterized pathologically by having a lymphoid stroma with germinal centers.

Kunio Mochizuki, Naoki Oishi, Masataka Kawai, Toru Odate, Ippei Tahara, Tomohiro Inoue, Kazunari Kasai, Tetsuo Kondo

Abstract read
PubMed Publisher
In one paragraph

Article in Histology and histopathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kunio MochizukiDepartment of Pathology, University of Yamanashi, Chuo, Japan. kuniom@yamanashi.ac.jp.
Naoki OishiDepartment of Pathology, University of Yamanashi, Chuo, Japan.
Masataka KawaiDepartment of Pathology, University of Yamanashi, Chuo, Japan.
Toru OdateDepartment of Pathology, University of Yamanashi, Chuo, Japan.
Ippei TaharaDepartment of Pathology, University of Yamanashi, Chuo, Japan.
Tomohiro InoueDepartment of Pathology, University of Yamanashi, Chuo, Japan.
Kazunari KasaiDepartment of Pathology, University of Yamanashi, Chuo, Japan.
Tetsuo KondoDepartment of Pathology, University of Yamanashi, Chuo, Japan.
University of Yamanashi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Warthin tumor is a benign neoplasm of the salivary glands, histologically, the tumor has an oncocytic epithelial component forming uniform rows of cells surrounded by cystic spaces associated with a lymphoid stroma often showing the presence of germinal centers. The lymphoid stroma is a representative microscopic finding. If this lymphocytic accumulation is active, some sort of transmitter should exist between the Warthin tumor cells and lymphocytes. C-X-C motif chemokine ligand (CXCL12) 12, CXCL10 and C-C motif chemokine ligand 18 (CCL18) are a chemoattractant for lymphocytes in vivo. There is no report on the relationship between these chemokines and Warthin tumors. In this study, we investigated these chemokines expressions in 20 Warthin tumors using immunohistochemistry and reverse transcription polymerase chain reaction (RT-PCR). For comparison, we also enrolled samples of pleomorphic adenoma, which is another benign salivary gland tumor type without prominent lymphocytic infiltration. All Warthin tumors were immunopositive for CXCL12 and CXCL10, and these reactivities were diffuse. Meanwhile, the majority of pleomorphic adenomas were immunonegative for CXCL12 (95%), CXCL10 (80%) and CCL18 (85%). Warthin tumor and pleomorphic adenoma cases were significantly different in these immunostaining expressions (CXCL12, p<0.001; CXCL10, p<0.001; CCL18, p=0.024). We examined CXCL12, CXCL10 and CCL18 mRNA expressions of 3 representative Warthin tumor samples, each having these chemokines immunopositive areas detected by RT-PCR. Finding CXCL12 and CXCL10 expressions indicate that these chemokines may play a part in the formation of a lymphoid stroma within Warthin tumors. In regards to this phenomenon, the participation of CCL18 might be restrictive compared to CXCL12 and CXCL10.

Indexed as

AdenolymphomaBiomarkers, TumorChemokine CXCL10Chemokine CXCL12Chemokines, CCGerminal CenterHumansImmunohistochemistryImmunophenotypingLymphocytesReverse Transcriptase Polymerase Chain ReactionStromal CellsTumor MicroenvironmentBiomarkers, TumorCCL18 protein, humanChemokine CXCL10Chemokine CXCL12Chemokines, CCCXCL10 protein, humanCXCL12 protein, human

Identifiers

PMID34124768
OpenAlexW3166908995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.